European Medicines Agency: Corona RNA vaccines are safe during pregnancy
The European Union's drug regulator said on Tuesday, after a detailed review of several studies, that Covid-19 vaccines made using messenger RNA technology do not cause complications for pregnant women or fetuses.
The European Medicines Agency said that the review, which was based on studies of nearly 65,000 pregnancies at different stages, found no sign of an increased risk of complications, miscarriage, premature birth or serious side effects for fetuses after receiving vaccines that rely on this technology.
Pfizer and its German partner Biontech, in addition to Moderna, are currently providing the European Union with such vaccines.
Although the European Medicines Agency acknowledged some limitations in the data, it said the results were consistent across all studies.
"The benefits of receiving Covid-19 vaccines that use messenger RNA technology during pregnancy outweigh any potential risks to pregnant women and their fetuses," the agency said.
The review by an internal team also concluded that COVID-19 vaccines based on this technology are as effective in reducing the risks of hospitalization and death in pregnant women as they are in non-pregnant women.
Follow our latest local and sports news and the latest political and economic developments via Google news